The presence of high amounts of HBV-DNA in serum is associated with suppressed costimulatory effects of interleukin 12 on HBV-induced immune response

Journal of Hepatology

Volumn 30, Issue 3, 1999, Pages 353-358

  Schlaak, Jörg F ^a   Tully, Glenn ^a   Löhr, Hanns F ^a   Gerken, Guido ^a   Büschenfelde, Karl Hermann Meyer Zum ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Hepatitis B; Interleukin 12, Response to therapy; Viral load

Indexed keywords

INTERLEUKIN 12; VIRUS DNA;

ARTICLE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; PRIORITY JOURNAL; VIRUS LOAD;

EID: 0032992117     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80090-7     Document Type: Article

References (29)

1. Löhr HF, Gerken G, Schlicht HJ, Meyer zum Büschenfelde KH, Fleischer B. Low frequency of cytotoxic liver-infiltrating T lymphocytes specific for endogenous processed surface and core proteins in chronic hepatitis B. J Infect Dis. 168:1993;1133-1139.
2. Wakita T, Kakumu S, Yoshioka K, Ishikawa T, Iho Y, Shinagawa T. Cellular immune responses of peripheral blood mononuclear cells to HBV antigens during chronic and acute HBV infection. Digestion. 52:1992;26-33.
3. Böcher WO, Herzog HS, Herr W, Heermann K, Gerken G, Meyer zum Büschenfelde, et al. Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection. Clin Exp Immunol. 105:1996;52-58.
4. Penna A, Del Prete G, Cavalli A, Bertoletti A, D'Elios MM, Sorrentino R, et al. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology. 25:1997;1022-1027.
5. + T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection. J Virol. 69:1995;3358-3368.
6. Tsai SL, Chen PJ, Lai MY, Yang PM, Sung JL, Huang JH, et al. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens, Implications for hepatitis B e antigen seroconversion. J Clin Invest. 89:1992;87-96.
7. + T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e- minus hepatitis B virus mutants. Hepatology. 22:1995;61-68.
8. Rossol S, Marinos, Carucci P, Singer MV, Williams R, Naoumov NV. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J Clin Invest. 99:1997;3025-3033.
9. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 4:1996;25-36.
10. Cavanaugh VJ, Guidotti LG, Chisari FV. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J Virol. 71:1997;3236-3243.
11. Berg T, Teuber G, Rödig S, Naumann U, Zcuzem S, Hopf U. Therapic der chronischen Hepatitis B mit Interleukin 12. Z Gastroenterol. 36:1998;87.
12. Brook MG, McDonald JA, Karayiannis P, Caruso L, Forster G, Harris, et al. Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response. Gut. 30:1989;1116-1122.
13. Schlaak JF, Trippler M, Ernst I, Meyer zum Büschenfelde KH, Gerken G. Chronic hepatitis C: the viral load per liver cell before treatment as a new marker to predict long-term response to IFN-alpha therapy. J Hepatol. 27:1997;917-921.
14. Crowther RA, Kiselev NA, Bottcher B, Berriman JA, Borisova GP, et al. Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell. 77:1994;943-950.
15. Gerlich W, Thomssen R. Standardized detection of hepatitis B surface antigen: determination of its serum concentration in weight units per volume. Dev Biol Stand. 30:1975;78-87.
16. Manns M. Autoantibodies and antigens in liver diseases - updated. J Hepatol. 9:1989;272-280.
17. Schlaak JF, Hermann E, Ringhoffer M, Probst P, Gallati H, Meyer zum Büschenfelde KH, et al. Predominance of Thl-type T cells in synovial fluid of patients with Yersinia-induced reactive arthritis. Eur J Immunol. 22:1992;2771-2776.
18. Schlaak JF, Löhr H, Gallati H, Meyer zum Büschenfelde KH, Fleischer B. Analysis of the in vitro cytokine production by liver-infiltrating T cells of patients with autoimmune hepatitis. Clin Exp Immunol. 94:1993;168-173.
19. McHugh SM, Deighton J, Rifkin IR, Ewan PW. Kinetics and functional implications of Th1 and Th2 cytokine production following activation of peripheral blood mononuclear cells in primary culture. Eur J Immunol. 26:1996;1260-1265.
20. + lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 126:1997;946-954.
21. Mellors JW, Rinaldo J, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 272:1996;1167-1170.
22. + T cells on progression of HIV disease in a double-blind study of thymopentin. AIDS. 10:1996;159-165.
23. Berenguer M, Olaso V, Cordoba J, Gobernado M, Carrasco D, Berenguer J. Genome detection in liver and peripheral blood mononuclear cells: predictor factors of sustained response in patients with chronic hepatitis C. Eur J Gastroenterol Hepatol. 7:1995;899-903.
24. Ballardini G, Manzin A, Giostra F, Francesconi R, Groff P, Grassi A, et al. Quantitative liver parameters of HCV infection: relation to HCV genotypes, viremia and response to interferon treatment. J Hepatol. 26:1997;779-786.
25. Stoll BS, Repp R, Glebe D, Schaefer S, Kreuder J, Kann M, et al. Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients. J Virol. 71:1997;5399-5407.
26. Catterall AP, Murray LI, Zuckerman AJ, Harrison TJ. Southern hybridisation analysis of HBV DNA in peripheral blood leucocytes and of different cell types: changes during the natural history and with interferon-alpha therapy in patients with hepatitis B virus infection. J Med Virol. 43:1994;269-275.
27. Trippler M, Hampl H, Goergen B, Spies U, Knolle P, Grimm B, et al. Ligase chain reaction (LCR) assay for semi-quantitative detection of HBV DNA in mononuclear leukocytes of patients with chronic hepatitis B. J Viral Hepat. 3:1996;267-272.
28. Oquendo J, Dubanchet S, Capel F, Mabit H, Petit MA. Suppressive effect of hepatitis B virus on the induction of interleukin-1 beta and interleukin-6 gene expression in the THP-1 human monocytic cell line. Eur Cytokine Netw. 7:1996;793-800.
29. Chen C, Zhou Y, Yao Z, Zhang Y, Feng Z. Stimulation of human lymphocyte proliferation and CD40 antigen expression by phosphorothioate oligonuclcotides complementary to hepatitis B virus genome. J Viral Hepat. 3:1996;167-172.